Testing chromium in drinking water
Dionex has updated its methods to allow for more sensitive testing of toxic hexavalent chromium in drinking water.
Dionex has updated its methods to allow for more sensitive testing of toxic hexavalent chromium in drinking water. Concern about the dangers of hexavalent chromium in drinking water has been rising as the National Toxicology Program of the US Department of Health and Human Services has said that chromium-6 in drinking water shows evidence of carcinogenic activity. In addition, after the US EPA released a toxicological review of hexavalent chromium, the California Office of Environmental Health Hazard Assessment agency issued a new public health guideline setting the limit for chromate at 0.02 ppb in drinking water.
In response, Dionex has announced the release of Application Update 179: Sensitive Determination of Hexavalent Chromium in Drinking Water. According to the company this application update demonstrates a very sensitive ion chromatography method for determining hexavalent chromium at the proposed California level of 0.02 μg/L. Using the company’s 2 mm IonPac AG7 guard and AS7 analytical columns, the method appropriately reduces the flow-rates and reaction coil volume.
For more information visit www.dionex.com
This story originally appeared in The Column. Click here to view that issue.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
